Cambrian BioPharma Inc's Form 4 filing
Faeth Therapeutics, Inc. (FTH) · filed Dec 10, 2025
- Accession no.
- 0000897069-25-001795
- Filed
- Dec 10, 2025
- Trade date
- Dec 9, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $54.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cambrian BioPharma IncCIK 0001797409 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Common Stock | SSaleDisposed | −3,105 | $8.59 | −$26,671.95 | 158,254 | Direct | |
| Dec 9, 2025 | Common Stock | SSaleDisposed | −2,666 | $7.95 | −$21,194.7 | 155,588 | Direct | |
| Dec 9, 2025 | Common Stock | MOption exerciseAcquired | +395 | $6.40 | +$2,528 | 155,983 | Direct | Duplicate filing |
| Dec 9, 2025 | Common Stock | SSaleDisposed | −395 | $8.04 | −$3,175.8 | 155,588 | Direct | |
| Dec 9, 2025 | Common Stock | SSaleDisposed | −446 | $7.92 | −$3,532.32 | 155,142 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Common Stock | MOption exerciseDisposed | −395 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.